| Application no. and date | 99962610.4 (espacenet) (Federated) (European Patent Register), 19991115 | | Patent/reg. no. and date | DK/EP 1131316, 20040721 | | Publication date | 20010912 | | Priority no. and date | SE 9803952, 19981118, SE 9803953, 19981118 | | EP pub. no. and date |
EP 1131316 20010912 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | AST A2009 | | Inventor | ERICKSON, Magnus, AstraZeneca R&D Mölndal
S-431 83 Mölndal, SE,
GUSTAVSSON, Anders, AstraZeneca Bulk Production,Sweden
S-151 85 Södertälje, SE,
JOSEFSSON, Lars, AstraZeneca Bulk Production, Sweden
S-151 85 Södertälje, SE | | Representative | | | Opponent | | | IPC Class | A61K 31/41 (2006.01) , A61K 31/44 (2006.01) , A61K 9/28 (2006.01) , C07D 401/12 (2006.01) | | Title | Forbedret kemisk fremgangsmåde og farmaceutisk præparat | | Int. application no. | SE1999002093 | | Int. publication no. | WO2000028975 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
